Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10 XW0333A
ICD-10-PCS code XW0333A for Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10 is a medical classification as listed by CMS under Anatomical Regions range.
ICD-10-PCS Code Symbols
: NewOfficial Code Descriptor
Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10
Crosswalks
Tabs
No record found
Crosswalk an ICD-10-PCS code to CPT®
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Body Part(3) | Approach(3) | Device / Substance / Technology(3) | Qualifier(A) |
| New Technology | Anatomical Regions | Introduction | Peripheral Vein | Percutaneous | Durvalumab Antineoplastic | New Technology Group 10 |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Added | 10-01-2024 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
